Tryvio (aprocitentan) nominated for the 2025 Prix Galien USA “Best Pharmaceutical Product” – Idorsia
Idorsia announced that The Galien Foundation, a premier global institution dedicated to honoring innovators in life sciences, has nominated Tryvio (aprocitentan) in the category of “Best Pharmaceutical Product”… read more.
